These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 32596739)
21. Clinical and microbiological characteristics of Staphylococcus lugdunensis. Cronin KM; Moso MA; Chan E; Bond KA Curr Opin Infect Dis; 2022 Dec; 35(6):524-529. PubMed ID: 36305373 [TBL] [Abstract][Full Text] [Related]
22. May Staphylococcus lugdunensis Be an Etiological Factor of Chronic Maxillary Sinuses Infection? Kosecka-Strojek M; Wolska-Gębarzewska M; Podbielska-Kubera A; Samet A; Krawczyk B; Międzobrodzki J; Michalik M Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742895 [TBL] [Abstract][Full Text] [Related]
23. Coagulase negative staphylococci - a fast emerging threat. Latif M; Usman J; Gilani M; Munir T; Mushtaq M; Anjum R J Pak Med Assoc; 2015 Mar; 65(3):283-6. PubMed ID: 25933562 [TBL] [Abstract][Full Text] [Related]
24. Detection of Tekeli A; Öcal DN; Dolapçı İ Balkan Med J; 2020 Jun; 37(4):215-221. PubMed ID: 32270947 [TBL] [Abstract][Full Text] [Related]
25. Cross-sectional study of Staphyloccus lugdunensis prevalence in cats. Bierowiec K Sci Rep; 2020 Sep; 10(1):15417. PubMed ID: 32963280 [TBL] [Abstract][Full Text] [Related]
26. Clinical and microbiological characteristics of community-acquired Staphylococcus lugdunensis infections in Southern Taiwan. Wu AB; Wang MC; Tseng CC; Lin WH; Teng CH; Huang AH; Hung KH; Chiang-Ni C; Wu JJ J Clin Microbiol; 2011 Aug; 49(8):3015-8. PubMed ID: 21697317 [TBL] [Abstract][Full Text] [Related]
27. Phylogenetic Distribution of CRISPR-Cas Systems in Kao CY; Lu JJ; Lin LC; Lin HC; Chang SC Microbiol Spectr; 2021 Dec; 9(3):e0124721. PubMed ID: 34851176 [TBL] [Abstract][Full Text] [Related]
28. Integron-Related Resistance in New Emerged Staphylococcus lugdunensis Infection in Burn Patients. Pirbonyeh N; Emami A; Bazargani A; Javanmardi F; Hosseini SM; Derakhshan B J Burn Care Res; 2020 May; 41(3):598-603. PubMed ID: 31867617 [TBL] [Abstract][Full Text] [Related]
29. Unbiased species-level identification of clinical isolates of coagulase-negative Staphylococci: does it change the perspective on Staphylococcus lugdunensis? Elamin WF; Ball D; Millar M J Clin Microbiol; 2015 Jan; 53(1):292-4. PubMed ID: 25339392 [TBL] [Abstract][Full Text] [Related]
30. Is Staphylococcus lugdunensis Significant in Clinical Samples? Argemi X; Hansmann Y; Riegel P; Prévost G J Clin Microbiol; 2017 Nov; 55(11):3167-3174. PubMed ID: 28835477 [TBL] [Abstract][Full Text] [Related]
31. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Frank KL; Del Pozo JL; Patel R Clin Microbiol Rev; 2008 Jan; 21(1):111-33. PubMed ID: 18202439 [TBL] [Abstract][Full Text] [Related]
33. A case of vascular graft infection caused by Staphylococcus lugdunensis after femoropopliteal bypass operation. Hagiya H; Matsumoto M; Yamasawa T; Haruki Y; Otsuka F Acta Med Okayama; 2014; 68(3):171-5. PubMed ID: 24942796 [TBL] [Abstract][Full Text] [Related]
34. Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices. Seng P; Traore M; Lavigne JP; Maulin L; Lagier JC; Thiery JF; Levy PY; Roger PM; Bonnet E; Sotto A; Stein A Int Orthop; 2017 Jun; 41(6):1085-1091. PubMed ID: 28405808 [TBL] [Abstract][Full Text] [Related]
35. Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin. Ma XX; Wang EH; Liu Y; Luo EJ J Med Microbiol; 2011 Nov; 60(Pt 11):1661-1668. PubMed ID: 21799199 [TBL] [Abstract][Full Text] [Related]
36. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci]. Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378 [TBL] [Abstract][Full Text] [Related]
37. Genotypes and phenotypes of Staphylococcus lugdunensis isolates recovered from bacteremia. Tseng SP; Lin YT; Tsai JC; Hung WC; Chen HJ; Chen PF; Hsueh PR; Teng LJ J Microbiol Immunol Infect; 2015 Aug; 48(4):397-405. PubMed ID: 24388577 [TBL] [Abstract][Full Text] [Related]
38. Clinical and microbiological properties of Staphylococcus lugdunensis skin infections. Zaaroura H; Geffen Y; Bergman R; Avitan-Hersh E J Dermatol; 2018 Aug; 45(8):994-999. PubMed ID: 29897142 [TBL] [Abstract][Full Text] [Related]
39. Successful daptomycin treatment for Staphylococcus lugdunensis endocarditis. Stair B; Vessels B; Overholser E; Zogleman B; Wall BM; Corbett C Am J Med Sci; 2012 Jul; 344(1):64-6. PubMed ID: 22314107 [TBL] [Abstract][Full Text] [Related]
40. Staphylococcus lugdunensis: low prevalence and clinical significance in a pediatric microbiology laboratory. German GJ; Wang B; Bernard K; Stewart N; Chan F; Pacheco AL; Wiebe D; Burdz T; Slinger R Pediatr Infect Dis J; 2013 Jan; 32(1):87-9. PubMed ID: 23241991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]